Beijert, Irene J.
Wever, Birgit M. M.
Hentschel, Anouk E.
van den Burgt, Yara
Kauer, Paul C.
Lissenberg-Witte, Birgit I.
van Moorselaar, R. Jeroen A.
Steenbergen, Renske D. M.
Nieuwenhuijzen, Jakko A.
Article History
Received: 17 April 2024
Accepted: 25 October 2024
First Online: 20 November 2024
Declarations
:
: Renske D. M. Steenbergen holds a minority stake in Self-screen B.V., a spin-off company of Amsterdam UMC, location VUmc, which owns patents and products related to the development of methylation markers for cervical screening. All other authors do not have any competing interest to declare.
: The study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Medical Ethics Committee (2018.355 [16-10-2018], WO 18.155 [21-12-2018]) and all participants provided informed written consent before inclusion in the study.